Table 1.
Microorganism | Culture Conditions (Synthesis Time) | Nanomaterial | Characterization | Biosynthetic Pathway | Application | Ref. |
---|---|---|---|---|---|---|
Bacillus subtilis | Enrichment medium, 35 °C, stirred at 170 rpm + 4 mM Na2SeO3 (48 h) | Se NPs | 50–400 nm; spherical regular morphology; 100 nm uniform single-crystalline; nanowires | Reduction mechanism of SeO32− ions to Se0 is yet to be elucidated | H2O2 sensoristic device | [19] |
Streptomyces minutisclero-ticus M10A62 | 5 g of wet bacterial biomass from 120 h cell culture + 1 mM Na2SeO3, stirred at 200 rpm (72 h) | Se NPs | 10–250 nm; spherical shape; crystalline; ζ-potential −19.1 mV |
Extracellular synthesis not described | Anti-biofilm, antioxidant activity, antiviral activity against Dengue virus; anti-proliferative activity against HeLa and HepG2 cell lines | [21] |
Pantoea agglomerans strain UC-32 | 1% (v/v) of an overnight cell culture in tryptic soy broth + 1 mM Na2SeO3, 25 °C (24 h) | Se NPs | <100 nm; spherical shape; amorphous form size vary with culture time (10–24 h); | Intracellular reduction of Se (IV) to Se (0) and subsequent excretion | High antioxidant activity (when stabilized with L-cysteine) | [29] |
Streptomyces bikiniensis strain Ess_amA-1 | 1 mL fresh bacteria inoculums (OD600 = 0.5 a.u.) in international Streptomyces Project 2 medium + 1 mM SeO2, 30 °C, stirred at 150 rpm (48 h) | Se NPs | 600 nm length, 17 nm diameter | Possible involvement of proteins/enzymes in SeO2 reduction nucleation, growth, stabilization of nanorods | In vitro anticancer activity against human breast adenocarcinoma cell line and human liver carcinoma cell line | [32] |
Escherichia coli DH5α | 10 h culture, resuspended in sterile distilled water + 1 mM HAuCl4, room temperature (120 h) | Au NPs | 25 ± 8 nm; spherical shape; crystalline form (face centered cubic phase) | Extracellular synthesis possibly modulated by sugars or enzymes present onto bacteria surface | Direct electro-chemistry of hemoglobin | [20] |
Shewanella oneidensis MR-1 |
Washed cell pellet from a 24 h cell culture + 1 mM HAuCl4, 30 °C, stirred at 200 rpm (48 h) | Au NPs | 12 ± 5 nm; spherical shape, capping proteins easily removable but not identified |
Extracellular synthesis possible electron shuttle-based enzymatic reduction of ionic Au3+ to Au0 | No antibacterial properties/annealing and thin film formation | [23] |
Nocardiopsis sp. MBRC-48 | Cell-free supernatant (from a 96 h cell culture) + 0.9 mM HAuCl4, incubated in the dark, 35 °C, stirred at 180 rpm (48 h) | Au NPs | 11.57 ± 1.24 nm; spherical shape; face centered cubic; polydispersed without significant structure |
Extracellular synthesis using the cell free supernatant, proteins, enzymes and metabolites | High antimicrobial activity against Staphylococcus aureus and Candida albicans, antioxidant activity and cytotoxic activities | [25] |
Brevibacterium casei | 1 g of wet bacterial biomass + 1 × 10−3 M AgNO3 + 1 × 10−3 M HAuCl4, 37 °C, stirred at 200 rpm (24 h) | Au and Ag NPs | Ag 10–50 nm, Au, 0–50 nm; spherical shape, crystalline form (face centered cubic phase) | Intracellular synthesis, possible roles of NADH-dependent nitrate reductase (for Ag NPs) and α-NADPH-dependent sulfite reductase (for Au NPs) | Anti-coagulant properties | [31] |
Shewanella oneidensis MR-1 | ∼3–5 g of wet bacterial biomass from 24 h cell culture + 1 mM AgNO3, 30 °C stirred at 200 rpm (48 h | Ag NPs | ∼2–11 nm spherical shape; crystalline form; ζ-potential = −16.5 mV |
Extracellular synthesis by secreted factors (e.g., NADH-dependent reductases, quinines, soluble electron-shuttles) | Antibacterial activity against Escherichia coli and Bacillus subtilis | [24] |
Lyngbya majuscula (CUH/Al/MW-150) | 100 mg of fresh weight biomass + 9 mM Ag(I) solution (pH 4) incubated in the dark, room temperature (72 h) | Ag NPs | ∼5–50 nm; spherical shape, crystalline form (face-centered cubic), smooth surface morphology, both (sonication) ζ-potential = −35.2 mV |
Extracellular and intracellular synthesis not described | Effective antibacterial activity against Pseudomonas aeruginosa; appreciable anti-proliferative effect on leukemic cells, especially on the REH cell line | [26] |
Streptomyces s. Al-Dhabi-87 | Broth-free cell pellets (14-days cell culture) in sterile distilled water for 1 h; cell removed from the suspension + 1–5 mM AgNO3, 37 °C (48 h) | Ag NPs | 20–50 nm; spherical shape | Extracellular synthesis possibly via hydrophilic and hydrophobic small metabolites attached on the bacteria cell wall | In vitro antimicrobial activity against Bacillus subtilis, Enterococcus faecalis, Staphylo-coccus epi-dermidis, and multidrug resistant Staphylococcus aureus strain | [27] |
Bacillus licheniformis | 2 g of wet bacterial biomass + 1 mM AgNO3, 37 °C, stirred at 200 rpm (24 h) | Ag NPs | 40 nm to 50 nm | N/A | Possible application as anti-proliferative and anti-migration agent e.g., against diabetic retinopathy, neoplasia and rheumatoid arthritis | [30] |
Escherichia coli K12 (ATCC 29181) | Bacterial culture (OD600 = 0.6 a.u.), Luria Bertani medium + 3 mM CdCl2 + 6 mM Na3C6H5O7 + 0.8 mM Na2TeO3, 8 mM C4H6O4S + 26 mM NaBH4, 37 °C, stirred at 200 rpm (24 h) | CdTe QDs | ∼2–3 nm; uniform size, cubic crystals; strong fluorescence emission shift with increasing quantum dots size, capping proteins were not identified but enhance QDs biocompatibility; ζ-potential = −19.1 mV |
Extracellular synthesis possibly via protein-assisted nucleation biosynthesis | Possible application in vitro cell imaging (demonstrated on HeLa cells) and bio-labeling | [22] |
Acetobacter xylinus GIM1.327 | Static culture in polysaccharides enriched medium, 30 °C (120 h) | Bacterial nanocellulose nanofibrils impregnated with Ag-NPs |
Nanoporous three-dimensional network structure with a random arrangement of ribbon-shaped microfibrils without any preferential orientation; 2 to 100 nm (Ag NPs) |
Intracellular-extracellular synthesis via enzymes glucokinase, phosphoglucomutase, UDPG, pyro-phospho-rylase and cellulose synthase | In vitro pH-responsive antimicrobial activity against Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 6538, Bacillus subtilis ATCC 9372 and Candida albicans CMCC(F) 98001 | [28,35] |
Acetobacter xylinum | N/A | Ag NPs and bacterial nano-paper composite | AgNPs 10–50 nm | Intracellular-extracellular synthesis of bacterial nanocellulose via enzymes glucokinase, phosphoglucomutase, UDPG, pyro-phospho-rylase and cellulose synthase AgNPs synthesis via direct chemical reduction of Ag+ mediated by baring hydroxyl groups of bacterial nanocellulose |
Optical detection of cyanide ion and 2-mercaptobenzo-thiazole in water samples | [35,36] |
Acetobacter xylinum | Static culture containing 50 g/L glucose, 5 g/L yeast extract, 5 g/L (NH4)2SO4, 4 g/L KH2PO4 and 0.1 g/L MgSO4·7H2O, 28 °C (366 h) | Nanocompositesof bacterial nanocellulose with AgNP, Au-NPs CdSe@ZnS quantum dots functionalized with biotinylated antibodies, aminosilica-coated lanthanide-doped up-conversion NPs | (bacterial nanocellulose) 45 ± 10 nm (fiber mean diameter); estimated length > 10 μm | Intracellular-extracellular synthesis via enzymes glucokinase, phosphoglucomutase, UDPG, pyro-phospho-rylase and cellulose synthase | Optical detection of methimazole, thiourea, cyanide, and iodide and Escherichia coli; possible uses in analytes pre-concentration platform | [35,37] |
Bacillus marisflavi GS3 | 200 mg biomass + 2.4 × 10−5 M graphene oxide dispersion mixture, 37 °C (72 h) | Reduced graphene oxide nanosheets | ~4.3 nm (average thickness), significant reduction of GO (assessed by XRD analysis); several layers stacked on top of one another like silky sheets of paper (SEM image) | Extracellular synthesis not described | Inhibition of cell viability, reactive oxygen species (ROS) generation, and membrane integrity alteration in MCF-7 cell line | [33] |
Magnetospirillum magneticum AMB-1 (Genetically modified) | Anaerobically grown in 5 ml/L of Wolfe’s mineral solution (without iron), + 5 mM KH2PO4 + 10 mM NaNO3 + 0.85 mM C2H3NaO2 + 0.2 mM C6H8O6 + 2.5 mM C4H6O6 + 0.6 mM Na2S2O3, pH 6.9; cell pellets were resuspended in 20 mM HEPES + 1 mM EDTA + 8% glycerol + 0.9% NaCl, pH 7.5 | Magnetosome (bio-mineralized iron-oxide nanoparticles coated by a biological membrane) |
Magnetosome membrane modified with Venus-RGD protein as specific and sensitive molecular imaging probe | Natural mechanism of magneto-somes formation (biomineralization) + genetic modification for Venus protein- RGD peptide expression |
Contrast agent for in vivo magnetic resonance-based molecular imaging | [47] |
Magnetospirillum magneticum strain AMB-1 | Micro-anaerobically grown in a similar culture medium of [47] | Whole inactive magnetotactic bacteria γ-Fe2O3 magnetosomes chains individual γ-Fe2O3 magnetosomes |
Magnetosomes chains (length) ∼150 or ∼300 nm; individual magnetosomes mean size ∼45 nm; well-crystallized monodomain with a ferromagnetic behavior at physiological temperature | Natural mechanism of magneto-somes formation + genetic modification for Venus protein- RGD peptide expression | Antitumoral activity against MDA-MB-231 breast cancer cells under alternating magnetic field stimulation | [48] |
Magnetospirillum gryphiswaldense strain MSR-1 | Micro-anaerobically grown in a similar culture medium of [47] and [48] + 50μM Fe(III) citrate | Chains of magnetosomes | Magnetosome membrane modified with Red-emitting Click Beetle luciferase (CBR) | Natural mechanism of magneto-somes formation + genetic modification for red-emitting click beetle luciferase expression | Toxicity assay on microfluidic chip for the detection of toxicity effect on membrane by DMSO and TCDCA | [49] |